Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Tech Selloff Deepens as OpenAI IPO Doubts and Chip Fears Slam Global Markets

by Team Lumida
1 day ago
stock market candlestick chart on dark screen

Tech stocks dragged global markets lower Friday as chipmaker selloffs deepened, OpenAI's IPO may slip to 2027, and investors pulled money from US equities for the first time...

Read more

JPMorgan Names Rohrbaugh and Petno Co-Presidents as Race to Succeed Dimon Takes Shape

by Team Lumida
1 day ago
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

JPMorgan Chase named Troy Rohrbaugh and Doug Petno co-presidents, positioning the FX trading veteran Rohrbaugh as the front-runner to eventually succeed CEO Jamie Dimon, while Marianne Lake departs...

Read more

Apple Hikes Mac and iPad Prices by Up to $300 as Memory Costs Quadruple

by Team Lumida
1 day ago
Can Apple’s Vision Pro Bounce Back with a Budget-Friendly Model?

Apple raised prices on Macs and iPads by $100–$300, blaming a quadrupling of DRAM and NAND memory costs, in a break from its historically aggressive pricing posture. Shares...

Read more

JPMorgan Expands German Wealth Push With New Hamburg Private Banking Office

by Team Lumida
2 days ago
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

JPMorgan Chase is opening a private banking office in Hamburg this August or September, its second German wealth management location after Munich, as it bets on Germany's regionally...

Read more

Gold Breaks Below $4,000 as Hawkish Fed and Dollar Strength End Three-Year Bull Run

by Team Lumida
2 days ago
stacked gold bullion bars

Gold fell as much as 0.9% to near $3,964 — below $4,000 for the first time since November — as a resurgent dollar, hawkish Fed repricing, and the...

Read more

Stratospheric Chip Rally Leaves Tech Stocks Exposed as Micron and Sandisk Crater 13%

by Team Lumida
3 days ago
stock market candlestick chart on dark screen

The Nasdaq fell 2.2% Tuesday as Micron and Sandisk — up 269% and 727% in 2026 — each dropped 13%+, with looming Fed rate hikes and AI spending...

Read more

SpaceX Sells $25 Billion in Bonds — and Cuts Its Annual Interest Bill in the Process

by Team Lumida
3 days ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

SpaceX closed the books on Musk's X/xAI debt consolidation with a $25B investment-grade bond sale drawing $89B in orders, replacing $17.5B in junk-rated debt at rates of 9.5-12.5%...

Read more

AI Rally Reverses Hard: Nasdaq Drops 2%, Chips Crater, SpaceX Dips Below IPO Open

by Team Lumida
4 days ago
stock market candlestick chart on dark screen

The tech selloff is accelerating — Nasdaq off 2%+, Micron down 11%, South Korea's Kospi diving 10% — as AI spending jitters and looming Fed rate hikes put...

Read more

The Greenspan Put Is on Hold — and the Next Crash Will Reveal If It Still Exists

by Team Lumida
4 days ago
The Greenspan Put Is on Hold — and the Next Crash Will Reveal If It Still Exists

Alan Greenspan's death at 100 prompts a reckoning: the Fed Put that defined three decades of market behavior may be suspended as long as inflation stays above target,...

Read more

SpaceX Shares Stabilize Near $2 Trillion After Three-Day, $600 Billion Rout

by Team Lumida
4 days ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

SpaceX stock turned positive in premarket trading after shedding over $600 billion in three sessions, as AI spending fears rattle high-momentum tech names and the company prepares a...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Foxconn Shares Rise After Chairman Says Met With OpenAI, Plans Nvidia Next

Foxconn Shares Rise After Chairman Says Met With OpenAI, Plans Nvidia Next

October 16, 2025
Elon Musk Reignites Legal Battle Against OpenAI and Sam Altman

Elon Musk Wanted Tesla to Take Over OpenAI, Romantic Partner Testifies in Court

May 7, 2026
Why Bitcoin’s “Wild Weekends” Are Over: Insights from Kaiko

XRP Leads 2024 Crypto Rally on Anticipated Pro-Crypto Regulatory Shift Under Trump Administration

December 24, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018